109 related articles for article (PubMed ID: 35304030)
21. Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy.
Duffaud F; Digue L; Mercier C; Dales JP; Baciuchka-Palmaro M; Volot F; Thomas P; Favre R
Eur J Cancer; 2003 Sep; 39(14):2050-7. PubMed ID: 12957460
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy.
Ferrari S; Bacci G; Picci P; Mercuri M; Briccoli A; Pinto D; Gasbarrini A; Tienghi A; Brach del Prever A
Ann Oncol; 1997 Aug; 8(8):765-71. PubMed ID: 9332684
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
24. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
Xu J; Xie L; Guo W
Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
[TBL] [Abstract][Full Text] [Related]
26. Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis.
Tirtei E; Asaftei SD; Manicone R; Cesari M; Paioli A; Rocca M; Ferrari S; Fagioli F
Tumori; 2018 Jun; 104(3):202-206. PubMed ID: 30086698
[TBL] [Abstract][Full Text] [Related]
27. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
28. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
[TBL] [Abstract][Full Text] [Related]
29. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P
Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205
[TBL] [Abstract][Full Text] [Related]
30. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
31. Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival.
Saeter G; Høie J; Stenwig AE; Johansson AK; Hannisdal E; Solheim OP
Cancer; 1995 Mar; 75(5):1084-93. PubMed ID: 7850705
[TBL] [Abstract][Full Text] [Related]
32. High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma.
Sauerbrey A; Bielack S; Kempf-Bielack B; Zoubek A; Paulussen M; Zintl F
Bone Marrow Transplant; 2001 May; 27(9):933-7. PubMed ID: 11436103
[TBL] [Abstract][Full Text] [Related]
33. Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma.
Scobioala S; Ranft A; Wolters H; Jabar S; Paulussen M; Timmermann B; Juergens H; Hassenpflug W; Klingebiel T; Elsayad K; Eich HT; Dirksen U
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):584-592. PubMed ID: 30244879
[TBL] [Abstract][Full Text] [Related]
34. Bone Infarct-Associated Osteosarcoma: Epidemiologic and Survival Trends.
Laranga R; Focaccia M; Evangelista A; Lucarelli E; Donati DM; Spazzoli B
Oncol Res Treat; 2022; 45(6):326-335. PubMed ID: 35034028
[TBL] [Abstract][Full Text] [Related]
35. High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study.
Fagioli F; Aglietta M; Tienghi A; Ferrari S; Brach del Prever A; Vassallo E; Palmero A; Biasin E; Bacci G; Picci P; Madon E
J Clin Oncol; 2002 Apr; 20(8):2150-6. PubMed ID: 11956277
[TBL] [Abstract][Full Text] [Related]
36. Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience.
Büyükkapu Bay S; Kebudi R; Görgün O; Zülfikar B; Darendeliler E; Çakır FB
J Oncol Pharm Pract; 2019 Sep; 25(6):1343-1348. PubMed ID: 30080131
[TBL] [Abstract][Full Text] [Related]
37. Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group.
Lavit E; Aldea M; Piperno-Neumann S; Firmin N; Italiano A; Isambert N; Kurtz JE; Delcambre C; Lebrun V; Soibinet-Oudot P; Chevreau C; Bompas E; Le Maignan C; Boudou-Rouquette P; Le Cesne A; Mancini J; Blay JY; Duffaud F
Int J Cancer; 2022 Feb; 150(4):645-653. PubMed ID: 34562271
[TBL] [Abstract][Full Text] [Related]
38. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
Nataraj V; Batra A; Rastogi S; Khan SA; Sharma MC; Vishnubhatla S; Bakhshi S
J Surg Oncol; 2015 Nov; 112(6):662-8. PubMed ID: 26381138
[TBL] [Abstract][Full Text] [Related]
39. Response to Pazopanib in Patients With Relapsed Osteosarcoma.
Elete KR; Albritton KH; Akers LJ; Basha R; Ray A
J Pediatr Hematol Oncol; 2020 May; 42(4):e254-e257. PubMed ID: 30531600
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of prognostic factors of osteosarcoma.
Ding WZ; Liu K; Li Z; Chen SR
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4103-4112. PubMed ID: 32373946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
